Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 11 fludarabine phosphate 8 Nivolumab 8 pembrolizumab 7 fludarabine 7 Mycophenolic Acid 6 Magnetic Resonance Spectroscopy 6 Filgrastim 6 Doxorubicin 6 Dacarbazine 6 Brentuximab Vedotin 6 Whole-Body Irradiation 5 Vinblastine 5 Granulocyte Colony-Stimulating Factor 5 Cyclosporine 5 Specimen Handling 4 Melphalan 4 Etoposide 4 Busulfan 4 pegfilgrastim 3 Tacrolimus 3 Radiotherapy 3 Thiotepa 2 Sirolimus 2 Radiation 2 Peripheral Blood Stem Cell Transplantation 2 Fluorodeoxyglucose F18 2 Cyclosporins 2 Clofarabine 2 Azacitidine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Hodgkin Disease × axatilimab × 30 days × Clear all

NCT05723055 2026-05-08

NAHL

University of Utah

Phase 2 Active not recruiting

Hodgkin Disease

Data powered by HemOnc (CC BY 4.0) Colophon ⚡